Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Organisation › Details

Roche GlycArt AG

GlycArt, a Swiss biotechnology company owned by Roche, is focused on antibody engineering to generate new, more efficacious drug candidates that are jointly developed with Roche. GlycArt is located in Schlieren, was founded in 2000 as a spin-off of the Swiss Federal Institute of Technology (ETH)-Zurich, and was acquired by Roche in 2005. *


Period Start 2005-07-01 renamed date ca
  Group Roche (Group)
  Predecessor GlycArt Biotechnology AG (CH)
Products Industry BIOTECH
  Industry 2 GlycoMAB technology
Region Region Schlieren ZH
  Country Switzerland
  Street 18 Wagistr.
  City 8952 Schlieren ZH
  Tel +41-44-755-6161
    Address record changed: 2018-07-24
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2017-04-01


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Roche (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

» top